Cargando…
The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer’s Disease
Alzheimer’s disease (AD) is an intractable, neurodegenerative disease that appears to be brought about by both genetic and non-genetic factors. The neuropathology associated with AD is complex, although amyloid plaques composed of the β-amyloid peptide (Aβ) are hallmark neuropathological lesions of...
Autores principales: | Cole, S.L, Vassar, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647160/ https://www.ncbi.nlm.nih.gov/pubmed/19415126 http://dx.doi.org/10.2174/138920207783769512 |
Ejemplares similares
-
The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007) -
BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
por: Vassar, Robert
Publicado: (2016) -
The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
por: Vassar, Robert, et al.
Publicado: (2011) -
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012) -
BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2013)